Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ATP2C2 |
| Upstream (Parents) |
|---|
| (<<) B3GNT3 → ATP2C2 |
| (<<) CCNB2 → ATP2C2 |
| (<<) CDCP1 → ATP2C2 |
| (<<) FA2H → ATP2C2 |
| (<<) FUT2 → ATP2C2 |
| (<<) FZD4 → ATP2C2 |
| (<<) G0S2 → ATP2C2 |
| (<<) GDF15 → ATP2C2 |
| (<<) MST1R → ATP2C2 |
| (<<) PLK1 → ATP2C2 |
| (<<) PRSS3 → ATP2C2 |
| (<<) RDX → ATP2C2 |
| (<<) RPIA → ATP2C2 |
| (<<) SFN → ATP2C2 |
| (<<) TK1 → ATP2C2 |
| (<<) TSPAN3 → ATP2C2 |
| (<<) UBE2C → ATP2C2 |
| Downstream (Children) |
|---|
| ATP2C2 → ANGPTL4 (>>) |
| ATP2C2 → BAALC (>>) |
| ATP2C2 → CDR2 (>>) |
| ATP2C2 → EPHB3 (>>) |
| ATP2C2 → FGF5 (>>) |
| ATP2C2 → INF2 (>>) |
| ATP2C2 → ITPR1 (>>) |
